CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 471851754
- Phone
- 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- 4 Shares withheld for taxes Chief Legal Officer gave up 11,395 shares (to pay taxes)
- 144 Insider Sale of Securities
- 424B5 Offering Prospectus
- 8-K Event Other events
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Planned sale Director sold 10,000 shares at $10.11 ($101,052)
- 4 Grant or award Chief Financial Officer acquired 58,869 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Planned sale Director sold 10,000 shares at an average $11.56 ($115,588)
- 4 Option exercise Director acquired 36,316 shares (option exercise)
- 8-K Event Executive or director change
- 4 Grant or award Chief Medical Officer acquired 58,386 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 56,446 shares (grant or award)
- 4 Planned sale Director sold 10,100 shares at an average $13.51 ($136,454)
Page 8 of 41 · 806 filings